Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,700
Bio-Rad Laboratories Inc News & Analysis
stocks
10 cheap wide-moat US stocks for 2025
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,065.70 | 11.20 | -0.12% |
| CAC 40 | 7,964.77 | 109.46 | -1.36% |
| DAX 40 | 23,734.02 | 315.72 | -1.31% |
| Dow JONES (US) | 46,912.30 | 398.70 | -0.84% |
| FTSE 100 | 9,735.78 | 41.30 | -0.42% |
| HKSE | 26,283.52 | 202.38 | -0.76% |
| NASDAQ | 23,053.99 | 445.80 | -1.90% |
| Nikkei 225 | 49,888.48 | 995.20 | -1.96% |
| NZX 50 Index | 13,647.43 | 70.62 | 0.52% |
| S&P 500 | 6,720.32 | 75.97 | -1.12% |
| S&P/ASX 200 | 8,801.50 | 9.00 | -0.10% |
| SSE Composite Index | 4,000.06 | 7.70 | -0.19% |